Vis enkel innførsel

Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications

dc.contributor.authorGodman, Brian
dc.contributor.authorHill, Andrew
dc.contributor.authorSimoens, Steven
dc.contributor.authorSelke, Gisbert
dc.contributor.authorSelke Krulichová, Iva
dc.contributor.authorZampirolli Dias, Carolina
dc.contributor.authorMartin, Antony P.
dc.contributor.authorOortwijn, Wija
dc.contributor.authorTimoney, Angela
dc.contributor.authorGustafsson, Lars L.
dc.contributor.authorVončina, Luka
dc.contributor.authorKwon, Hye-Young
dc.contributor.authorGulbinovič, Jolanta
dc.contributor.authorGotham, Dzintars
dc.contributor.authorWale, Janet
dc.contributor.authorCristina Da Silva, Wânia
dc.contributor.authorBochenek, Tomasz
dc.contributor.authorAllocati, Eleonora
dc.contributor.authorKurdi, Amanj
dc.contributor.authorOgunleye, Olayinka O.
dc.contributor.authorMeyer, Johanna C.
dc.contributor.authorHoxha, Iris
dc.contributor.authorMalaj, Admir
dc.contributor.authorHierländer, Christian
dc.contributor.authorSauermann, Robert
dc.contributor.authorHamelinck, Wouter
dc.contributor.authorPetrova, Guenka
dc.contributor.authorLaius, Ott
dc.contributor.authorLangner, Irene
dc.contributor.authorYfantopoulos, John
dc.contributor.authorJoppi, Roberta
dc.contributor.authorJakupi, Arianit
dc.contributor.authorGreičiūtė-Kuprijanov, Ieva
dc.contributor.authorBonanno, Patricia Vella
dc.contributor.authorPiepenbrink, Jf
dc.contributor.authorde Valk, Vincent
dc.contributor.authorWladysiuk, Magdalene
dc.contributor.authorMarkovic-Pekovic, Vanda
dc.contributor.authorMardare, Ileana
dc.contributor.authorFürst, Jurij
dc.contributor.authorTomek, Dominik
dc.contributor.authorObach Cortadellas, Mercè
dc.contributor.authorZara, Corinne
dc.contributor.authorPontes, Caridad
dc.contributor.authorMcTaggart, Stuart
dc.contributor.authorLaba, Tracey-Lea
dc.contributor.authorMelien, Øyvind
dc.contributor.authorWong-Rieger, Durhane
dc.contributor.authorBae, SeungJin
dc.contributor.authorHill, Ruaraidh
dc.date.accessioned2022-04-06T06:51:32Z
dc.date.available2022-04-06T06:51:32Z
dc.date.created2022-01-22T18:33:23Z
dc.date.issued2021
dc.identifier.citationExpert review of pharmacoeconomics & outcomes research. 2021, 21 (4), 527-540.
dc.identifier.issn1473-7167
dc.identifier.urihttps://hdl.handle.net/11250/2990037
dc.language.isoeng
dc.titlePotential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.source.pagenumber527-540
dc.source.volume21
dc.source.journalExpert review of pharmacoeconomics & outcomes research
dc.source.issue4
dc.identifier.doi10.1080/14737167.2021.1884546
dc.identifier.cristin1987917
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail
Filnavn:
Godman_2021_Pot.pdf
Størrelse:
978.4Kb
Format:
PDF
Åpne

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel